DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Eberhardt WE. et al.
Feasibility of adding everolimus to carboplatin and paclitaxel, with or without bevacizumab, for treatment-naive, advanced non-small cell lung cancer.
Invest New Drugs 2014;
32: 123-134
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.
